SKIN Stock — Beauty Health Co

Beauty Health Co (SKIN)

Updated October 16, 2026.

SKIN is a Stock. Its deepest 1-year drawdown was 67.0%.

Beauty Health Co is a global medical aesthetics company that develops and markets skincare treatment devices and consumables, including its flagship HydraFacial system for cleansing and hydrating skin, as well as microneedling devices, scalp health solutions, and a mobile app connecting consumers with treatment providers. The company does not currently have an established distribution schedule. This stock may appeal to growth-oriented investors seeking exposure to the medical aesthetics and consumer health sectors.

SKIN performance

Returns are updating. SKIN's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 67.0%.

SKIN key facts

Asset type

Stock

Asset class

Equity

Inception date

11/24/2020

Distribution frequency

None

Last close

$10.56 (as of 2026-10-16)

Market cap

$1,374,286,457

Average volume

89012.0

Beta

1.05

Payout ratio

0.0%

Forward P/E

106.383

EPS

$-4.60

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

SKIN risks and drawbacks

The deepest 1-year drawdown on record here is 67.0%.

Who may consider SKIN — and who may not

It is a weaker fit for investors who need monthly cash flow (SKIN does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on SKIN

• All tickers starting with S

Tagged: Consumer Staples.

Frequently asked questions